FUNCTIONAL DISABILITY IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS

被引：0

作者：

Sari, A. ^{[1
]}

Armagan, B. ^{[1
]}

Erden, A. ^{[1
]}

Kilic, L. ^{[1
]}

Karadag, O. ^{[1
]}

Akdogan, A. ^{[1
]}

Bilgen, S. Apras ^{[1
]}

Kiraz, S. ^{[1
]}

Kalyoncu, U. ^{[1
]}

Ertenli, I. ^{[1
]}

机构：

[1] Hacettepe Univ, Sch Med, Rheumatol, Ankara, Turkey

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷

关键词：

D O I：

10.1136/annrheumdis-2017-eular.4098

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0226

引用

页码：1127 / 1127

页数：1

共 50 条

[1] RESULTS OF SCREENING FOR VIRAL HEPATITIS IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS
Sari, A.
Armagan, B.
Erden, A.
Kilic, L.
Akdogan, A.
Bilgen, S. Apras
Ertenli, I.
Kalyoncu, U.
Kiraz, S.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1175 - 1175
[2] RAID COMPOSITE INDEX IN THE EVALUATION OF RA PATIENTS RECEIVING BIOLOGICAL TREATMENT: HUR-BIO REAL-LIFE RESULTS
Erden, A.
Kilic, L.
Armagan, B.
Sari, A.
Akdogan, A.
Bilgen, S. A.
Karadag, O.
Ertenli, I.
Kiraz, S.
Kalyoncu, U.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1113 - 1113
[3] DURATION OF STARTING bDMARDs ARE ALMOST 3 TIMES LONGER IN RA PATIENTS THAN PsA PATIENTS: HUR-BIO REAL LIFE RESULTS
Yardimci, G. K.
Farisogullari, B.
Bolek, E. C.
Bilgin, E.
Duran, E.
Ayan, G.
Ozsoy, Z.
Uzun, G. Sandal
Kilic, L.
Akdogan, A.
Karadag, O.
Bilgen, S. A.
Kiraz, S.
Ertenli, A. I.
Kalyoncu, U.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 554 - 555
[4] ABATACEPT EXPERIENCE IN BIOLOGIC NAIVE RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Sari, A.
Armagan, B.
Kilic, L.
Erden, A.
Karadag, O.
Akdogan, A.
Bilgen, S. Apras
Kiraz, S.
Kalyoncu, U.
Ertenli, I.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 854 - 855
[5] THORAX CT FINDINGS IN A LARGE COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS
Sari, A.
Armagan, B.
Erden, A.
Kilic, L.
Karadag, O.
Akdogan, A.
Bilgen, S. Apras
Ertenli, I.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 256 - 256
[6] Fatigue May be Independently Active at a Certain Part of Spondyloarthritis Patients: Hur-BIO Real Life Results
Kalyoncu, Umut
Erden, Abdulsamet
Kilic, Levent
Seyhoglu, Emrah
Guven, Denizcan
Aktas, Burak Yasin
Sener, Yusuf Ziya
Karadag, Omer
Bilgen, Sule Apras
Akdogan, Ali
Kiraz, Sedat
Ertenli, Ihsan
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[7] ANKYLOSING SPONDYLITIS PATIENTS WITH UVEITIS HAD BETTER ADALIMUMAB RETENTION RATE: HUR-BIO REAL LIFE RESULTS
Armagan, B.
Sari, A.
Erden, A.
Kilic, L.
Guven, D. C.
Pashayev, T.
Bilgin, E.
Simsek, C.
Erdat, E. C.
Karadag, O.
Akdogan, A.
Bilgen, S. Apras
Kiraz, S.
Ertenli, I.
Kalyoncu, U.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1300 - 1301
[8] THE INFLUENCE OF OBESITY ON BIOLOGICAL DMARD TREATMENT RESPONSE IN PSORIATIC ARTHRITIS: HUR-BIO REAL LIFE RESULTS
Farisogullari, B.
Yardimci, G. K.
Bolek, E. C.
Bilgin, E.
Duran, E.
Ayan, G.
Kilic, L.
Karadag, O.
Akdogan, A.
Bilgen, S. A.
Ertenli, A. I.
Kiraz, S.
Kalyoncu, U.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1675 - 1676
[9] SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Armagan, B.
Kilic, L.
Yardimci, G. K.
Bilgin, E.
Farisogullari, B.
Bolek, E. C.
Duran, E.
Karadag, O.
Akdogan, A.
Bilgen, S. A.
Ertenli, A. I.
Kalyoncu, U.
Kiraz, S.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 419 - 420
[10] Patients with Psoriatic Arthritis Had Better TNFi Survival Than Ankylosing Spondylitis: HUR-BIO Real Life Results
Kalyoncu, Umut
Karadag, Omer
Kilic, Levent
Bilgen, Sule Apras
Erden, Abdulsamet
Akdogan, Ali
Kiraz, Sedat
Ertenli, Ihsan
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S64 - S64

← 1 2 3 4 5 →